Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy

Gabriele Calaminus(University Hospital Bonn), Rajaram Nagarajan(University of Minnesota), Cristina Sauerland(University of Münster), Babasola O Popoola(MRC Clinical Trials Unit at UCL), Gordana Jovic(MRC Clinical Trials Unit at UCL), Stefan Bielack(Olgahospital), C. Teske(University Hospital Münster), Jeremy Whelan(University College London Hospitals NHS Foundation Trust), Kiana Kreitz(University of Münster), Lars Hjorth(Lund University), Matthew R. Sydes(MRC Clinical Trials Unit at UCL), Meriel Jenney(Noah's Ark Children's Hospital for Wales), Patricia De Vos(Ghent University Hospital), Mark L. Bernstein(University of Louisville), Katja Baust(University Hospital Bonn), Andreas Wiener, Sigbjørn Smeland(Oslo University Hospital), Neyssa Marina(Coherus BioSciences (United States)), Clara V Schweinitz(University Hospital Bonn), Mark Krailo(Arcadia), Pancras C.W. Hogendoorn(Vrije Universiteit Brussel)
JMIR Research Protocols
September 26, 2019
10.2196/14406
Cited by 10

Related Papers

Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
|The Lancet|2015|2k
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
|New England Journal of Medicine|2017|1.8k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k